A variety of clinical and laboratory findings correlate with clinical outcome in patients with neuroblastoma.
Parameter |
Favorable |
Unfavorable |
age in years |
< 2 |
>= 2 |
histologic type according to Shimada et al |
favorable |
unfavorable |
clinical stage of Evans et al |
I, II, IVS |
III, IV |
lymphocytic infiltration |
present |
absent |
cytogenetics |
hyperdiploid |
diploid |
urinary VMA/HVA ratio |
>= 1 |
< 1 |
NSE |
normal (<= 100 ng/mL) |
increased (> 100 ng/mL) |
serum LDH |
low |
increased |
serum ferritin |
low (<= 150 ng/mL) |
increased (> 150 ng/mL) |
N-myc amplification |
absent |
present |
TRK gene expression (nerve growth factor receptor, NGFR) |
high |
low |
ganglioside Gt1b |
present |
absent |
bcl-2 expression |
absent |
present |
P-glycoprotein (multi-drug resistance protein) |
absent |
present |
where:
• the upper limit of serum ferritin in a child or young adolescent is about 140-150 ng/mL; the upper limit varies at other ages
Specialty: Hematology Oncology, Surgery, general